 EPD was available in the United States until 2001, when the Food and Drug Administration revoked approval for an investigative study which it had previously sanctioned.That study had allowed EPD to be imported into the United States without being licensed.The approval was revoked because the EPD treatments included complex mixtures of allergens that were not allowed under FDA rules.